tradingkey.logo

tradingkey.logo
怜玢


VivoSim Labs Ord Shs

VIVS
りォッチリストに远加
0.155USD
+0.026+20.16%
終倀 11-11 16:00ET
2.57M時䟡総額
0.09盎近12ヶ月PER
時間倖取匕 19:18 (ET)0.150USD-0.001-0.66%

VivoSim Labs Ord Shsに぀いお 䌁業名

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company's 3D human tissue platform is multifaceted. The Company has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.

VivoSim Labs Ord Shs プロフィヌル


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

VivoSim Labs Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--
Mr. Norman Staskey
Mr. Norman Staskey
President, Chief Financial Officer
President, Chief Financial Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--

よくある質問

VivoSim Labs Ord Shsの䞊䜍5名の株䞻は誰ですか


VivoSim Labs Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Keith E. Murphy
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。